Home › Compare › PLIXF vs MRK

PLIXF vs MRK: Dividend Comparison 2026

PLIXF yields 39215.69% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLIXF wins by $4.252735580217355e+22M in total portfolio value
10 years
PLIXF
PLIXF
● Live price
39215.69%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.252735580217355e+22M
Annual income
$42,315,093,309,418,040,000,000,000,000.00
Full PLIXF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — PLIXF vs MRK

📍 PLIXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPLIXFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PLIXF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PLIXF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PLIXF
Annual income on $10K today (after 15% tax)
$3,333,333.33/yr
After 10yr DRIP, annual income (after tax)
$35,967,829,313,005,333,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, PLIXF beats the other by $35,967,829,313,005,333,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PLIXF + MRK for your $10,000?

PLIXF: 50%MRK: 50%
100% MRK50/50100% PLIXF
Portfolio after 10yr
$2.1263677901086776e+22M
Annual income
$21,157,546,654,709,020,000,000,000,000.00/yr
Blended yield
99.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PLIXF
No analyst data
Altman Z
27.9
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PLIXF buys
0
MRK buys
0
No recent congressional trades found for PLIXF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPLIXFMRK
Forward yield39215.69% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$4.252735580217355e+22M$30.7K ✓
Annual income after 10y$42,315,093,309,418,040,000,000,000,000.00 ✓$950.29
Total dividends collected$4.251340866571809e+22M$6.1K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PLIXF vs MRK ($10,000, DRIP)

YearPLIXF PortfolioPLIXF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$3,932,269$3,921,568.63$11,192$351.54+$3.92M → PLIXF
2$1,445,390,825$1,441,183,297.58$12,524$392.70+$1445.38M → PLIXF
3$496,629,048,205$495,082,480,022.34$14,015$438.65+$496629.03M → PLIXF
4$159,510,701,964,776$158,979,308,883,196.16$15,682$489.96+$159510701.95M → PLIXF
5$47,892,225,784,148,210$47,721,549,333,045,900.00$17,547$547.23+$47892225784.13M → PLIXF
6$13,442,027,069,357,296,000$13,390,782,387,768,257,000.00$19,632$611.16+$13442027069357.28M → PLIXF
7$3,526,928,149,355,307,700,000$3,512,545,180,391,095,400,000.00$21,963$682.53+$3526928149355307.50M → PLIXF
8$865,104,634,553,737,800,000,000$861,330,821,433,927,700,000,000.00$24,571$762.18+$865104634553737856.00M → PLIXF
9$198,376,161,453,751,100,000,000,000$197,450,499,494,778,630,000,000,000.00$27,486$851.08+$198376161453751107584.00M → PLIXF
10$42,527,355,802,173,560,000,000,000,000$42,315,093,309,418,040,000,000,000,000.00$30,745$950.29+$4.252735580217355e+22M → PLIXF

PLIXF vs MRK: Complete Analysis 2026

PLIXF — Stock

Prairie Lithium Limited operates as a mineral exploration company in the United States and Canada. The company explores primarily for lithium deposits. It owns 100% interest in the Big Sandy Lithium project that comprises 331 bureau of land management (BLM) claims covering an area of approximately 25 square kilometers located in Arizona, the United States; and the Pairie Lithium project located in the southeast Saskatchewan. The company was formerly known as Arizona Lithium Limited and changed its name to Prairie Lithium Limited in September 2025. Prairie Lithium Limited was incorporated in 1969 and is based in West Perth, Australia.

Full PLIXF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this PLIXF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PLIXF vs SCHDPLIXF vs JEPIPLIXF vs OPLIXF vs KOPLIXF vs MAINPLIXF vs JNJPLIXF vs ABBVPLIXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.